Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19

Sponsor
Hospital de Clinicas de Porto Alegre (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04632082
Collaborator
(none)
2,200
1
2
8.4
260.6

Study Details

Study Description

Brief Summary

A pragmatic superiority randomized controlled trial comparing Telepsychoeducation plus personalized videos vs. Telepsychoeducation without personalized videos for the prevention of future emotional distress in professionals and students from essential services with low to moderate levels of emotional distress in Brazil.

Note: This study was approved by the Ethics and Research Committee of the Hospital de Clínicas de Porto Alegre and is originally registered at Plataforma Brasil, a Brazilian study registration platform (under CAAE: 30608420.5.0000.5327). Recruitment began in May 28th 2020.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Telepsychoeducation with personalized videos
  • Behavioral: Telepsychoeducation without personalized videos
N/A

Detailed Description

TITLE: "A pragmatic superiority randomized controlled trial comparing Telepsychoeducation plus personalized videos vs. Telepsychoeducation without personalized videos for the prevention of future emotional distress in professionals and students from essential services with low to moderate levels of emotional distress in Brazil"

IMPORTANCE: COVID-19 outbreak is associated with increased emotional distress (depression, anxiety and irritability) all over the world. Currently, there are no large randomized trials testing preventive interventions to reduce the burden caused by mental disorders after the occurrence of a pandemic outbreak in these proportions.

OBJECTIVE: To compare the effectiveness of Telepsychoeducation with personalized videos to Telepsychoeducaton without personalized videos for the prevention of severe symptoms of emotional distress (anxiety, depression and irritability) in health professionals with a low to moderate level of those symptoms in Brazil during the COVID-19 outbreak.

DESIGN, SETTING, AND PARTICIPANTS Two-group randomized clinical trial. Participants were recruited in Brazil from the national service of telehealth provided by the ministry of health. Participants included health professionals suffering from low to moderate levels of anxiety, depression and irritability symptoms during the COVID-19 outbreak. Low to moderate levels of symptoms were defined by all of the following: (1) z score lower than 1.5 on the PROMIS Anxiety Scale; (2) z score lower than 1.5 on the PROMIS Depression Scale; (3) z score lower than 1.5 on the PROMIS Anger Scale.

INTERVENTIONS: All participants were randomized to the Telepsychoeducation with personalized videos (1 session with a psychologist plus 1 videos a week for 4 weeks, chosen based on symptom presentation) or Telepsychoeducation without personalized videos (1 session with a psychologist focused on reassurance and aspects of the outbreak).

MAIN OUTCOMES AND MEASURES: The primary outcome will be the proportion of participants with a T score equal or above 70 in any of the emotional distress scales (anxiety, depression or irritability) in 6 months. Secondary outcomes (1) mean score change in individual scales at 1, 3 and 6 months; (2) proportion of participants with a T score equal or above 60 in any of the emotional distress scales at 1, 3 and 6 months; and (3) service satisfaction and net-promoter score at the end of the treatment.

EXPECTED RESULTS: To detect a 5% group difference between each group, an alpha of 0.05, power of 90% and 20% loss to follow up, in a 1:1 randomization, we would need a total of 1100 participants per group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-group randomized clinical trial including health professionals and health students suffering from low to moderate levels of anxiety, depression and irritability symptoms during the COVID-19 outbreak, randomized randomized 1:1 to the Telepsychoeducation with personalized videos (2 sessions with a psychologist plus 2 videos a week for 4 weeks chosen based on symptom presentation) or Telepsychoeducation without personalized videos (2 sessions with a psychologist focused on reassurane and aspects of the outbreak).Two-group randomized clinical trial including health professionals and health students suffering from low to moderate levels of anxiety, depression and irritability symptoms during the COVID-19 outbreak, randomized randomized 1:1 to the Telepsychoeducation with personalized videos (2 sessions with a psychologist plus 2 videos a week for 4 weeks chosen based on symptom presentation) or Telepsychoeducation without personalized videos (2 sessions with a psychologist focused on reassurane and aspects of the outbreak).
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Pragmatic Superiority Randomized Controlled Trial Comparing Telepsychoeducation Plus Personalized Videos vs. Telepsychoeducation Without Personalized Videos for the Prevention of Future Emotional Distress in Professionals From Essential Services With Low to Moderate Levels of Emotional Distress in Brazil in the Context of COVID-19
Actual Study Start Date :
Nov 5, 2020
Anticipated Primary Completion Date :
Jul 13, 2021
Anticipated Study Completion Date :
Jul 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention: Telepsychoeducation with personalized videos

One psychoeducation session administered by a therapist by video call, with interventions focused on promoting protective factors and reducing common risk factors for psychopathology. The intervention is complemented by the sending of 4 videos of 2 to 3 minutes, with psychoeducational content, sent each week by the therapist.

Behavioral: Telepsychoeducation with personalized videos
1 session with a psychologist plus 1 video a week for 4 weeks chosen based on symptom presentation

Active Comparator: Comparator: Telepsychoeducation without personalized videos

One psychoeducation session administered by a therapist by video call, with interventions focused on promoting protective factors and reducing common risk factors for psychopathology.

Behavioral: Telepsychoeducation without personalized videos
1 session with a psychologist focused on reassurance and aspects of the outbreak

Outcome Measures

Primary Outcome Measures

  1. Incident Cases in 6 months [6-months]

    Proportion of participants with a T score equal or above 70 in any of three emotional distress subscales (Patient-Reported Outcomes Measurement Information System - or PROMIS - of Depression, Anxiety and Anger)

Secondary Outcome Measures

  1. Incident cases [1, 3 an 6-months]

    Proportion of participants with a T score equal or above 60 in any of the emotional distress scales (PROMIS - of Depression, Anxiety and Anger)

  2. Service Satisfaction [2-weeks]

    Service satisfaction measured by the net-promoter score at the end of the treatment (proportion of promoters - scores of 9 or 10)

  3. Improvement in Quality of Life [1, 3 and 6-months]

    Mean score change in quality of life scale (PROMIS General Life Satisfaction Scale or GLSS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria (must present all of the following):

Professionals and students from essential services suffering from low to moderate emotional distress

  • z score lower than 1.5 on the PROMIS Anxiety Scale

  • z score lower than 1.5 on the PROMIS Depression Scale

  • z score lower than 1.5 on the PROMIS Anger Scale

Exclusion Criteria:
  • Moderate to severe suicide risk assessed by a psychiatrist

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital de Clínicas de Porto Alegre Porto Alegre Rio Grande Do Sul Brazil

Sponsors and Collaborators

  • Hospital de Clinicas de Porto Alegre

Investigators

  • Principal Investigator: Giovanni Salum, MD, PhD, Hospital de Clínicas de Porto Alegre, Porto Alegre/Brazil

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Giovanni Abrahao Salum Junior, Principal Investigator, Hospital de Clinicas de Porto Alegre
ClinicalTrials.gov Identifier:
NCT04632082
Other Study ID Numbers:
  • 20200213_Prevention
First Posted:
Nov 17, 2020
Last Update Posted:
Nov 20, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 20, 2020